taxonomy (1)
protein (1)
source (5)
structure (5)
composition (37)
disease (3)
reference (6)
site (5)
peptide (7)
- Homo sapiens (Human)
Taxonomy
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- Cerebrospinal Fluid Secretion (GO_0033326)
Source
- N-Linked / Complex / Structure 2011
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 3507
- N-Linked / Complex / Structure 644
- N-Linked / Complex / Structure 3534
Reported structure
- Hex:3 HexNAc:7 (avg mass : 1926.8075 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:5 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1875.7132 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2516.3091 )
- Hex:5 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2485.2982 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2678.4515 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 (avg mass : 2299.1307 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:3 (avg mass : 3172.9044 )
- Hex:6 HexNAc:5 dHex:3 (avg mass : 2445.2737 )
- Hex:6 HexNAc:5 dHex:3 NeuAc:3 (avg mass : 3319.0474 )
- Hex:6 HexNAc:5 dHex:4 NeuAc:1 (avg mass : 2882.6746 )
- Hex:6 HexNAc:5 dHex:7 (avg mass : 3029.8457 )
- Hex:6 HexNAc:6 (avg mass : 2210.0397 )
- Hex:6 HexNAc:6 dHex:1 (avg mass : 2356.1827 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2938.6985 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3229.9564 )
- Hex:7 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2694.4509 )
- Hex:7 HexNAc:6 NeuAc:3 (avg mass : 3245.9558 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:2 (avg mass : 2664.4681 )
- Hex:8 HexNAc:7 dHex:1 (avg mass : 2883.6625 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Computational framework for identification of intact glycopeptides in complex samples (2014 - Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H.) / Status : Reviewed
- Enrichment of glycopeptides for glycan structure and attachment site identification (2009 - Nilsson J, Rüetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G.) / Status : Reviewed
Reference
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
Reported glycosite
- KLPPGLLANFTLLR (14aa)
- KLPPGLLANFT (11aa)
- LPPGLLANFTLLR (13aa)
- QLDMLDLSNNSLASVPEGLWASLGQPNWDMR (31aa)
- MLDLSNNSLASVPE (14aa)
- DGFDISGNPWICDQNLSDLYR (21aa)
- MFSQNDTR (8aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 1479.3649)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
-
- N-Linked / Complex (avg mass : 1641.5073)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
-
- N-Linked / Complex (avg mass : 1932.7652)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
-
- N-Linked / Complex (avg mass : 2006.8447)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
-
- N-Linked / Complex (avg mass : 2152.9877)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
-
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1567.4278)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:5 HexNAc:3 dHex:1 NeuAc:1 / N-Linked (avg mass : 1875.7132)
- Blood Serum (UBERON_0001977)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- QLDMLDLSNNSLASVPEGLWASLGQPNWDMR (31aa)
-
- Hex:3 HexNAc:7 / N-Linked (avg mass : 1926.8075)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- N-Linked / Complex / Structure 3507
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- KLPPGLLANFTLLR (14aa)
- QLDMLDLSNNSLASVPEGLWASLGQPNWDMR (31aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Blood Serum (UBERON_0001977)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MLDLSNNSLASVPE (14aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 2094.9076)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- KLPPGLLANFTLLR (14aa)
- MFSQNDTR (8aa)
-
- Hex:6 HexNAc:6 / N-Linked (avg mass : 2210.0397)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- KLPPGLLANFTLLR (14aa)
- KLPPGLLANFT (11aa)
- LPPGLLANFTLLR (13aa)
- QLDMLDLSNNSLASVPEGLWASLGQPNWDMR (31aa)
- MFSQNDTR (8aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Prostate cancer (DOID:10283)
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- KLPPGLLANFTLLR (14aa)
- MFSQNDTR (8aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2241.0506)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- LPPGLLANFTLLR (13aa)
- DGFDISGNPWICDQNLSDLYR (21aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 2298.1026)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:6 HexNAc:5 dHex:2 / N-Linked (avg mass : 2299.1307)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:6 HexNAc:6 dHex:1 / N-Linked (avg mass : 2356.1827)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:12 HexNAc:2 / N-Linked (avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2444.2456)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:6 HexNAc:5 dHex:3 / N-Linked (avg mass : 2445.2737)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:5 HexNAc:6 dHex:1 NeuAc:1 / N-Linked (avg mass : 2485.2982)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 / N-Linked (avg mass : 2516.3091)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:7 HexNAc:6 dHex:1 / N-Linked (avg mass : 2518.3251)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:7 HexNAc:6 dHex:2 / N-Linked (avg mass : 2664.4681)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:6 HexNAc:4 dHex:2 NeuAc:2 / N-Linked (avg mass : 2678.4515)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- LPPGLLANFTLLR (13aa)
-
- Hex:7 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2694.4509)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2735.5035)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- LPPGLLANFTLLR (13aa)
-
- Hex:6 HexNAc:5 NeuAc:3 / N-Linked (avg mass : 2880.6184)
- Blood Serum (UBERON_0001977)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:6 HexNAc:5 dHex:4 NeuAc:1 / N-Linked (avg mass : 2882.6746)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:8 HexNAc:7 dHex:1 / N-Linked (avg mass : 2883.6625)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 2938.6985)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- LPPGLLANFTLLR (13aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked (avg mass : 3026.7614)
- Prostate cancer (DOID:10283)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:6 HexNAc:5 dHex:7 / N-Linked (avg mass : 3029.8457)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:3 / N-Linked (avg mass : 3172.9044)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3229.9564)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- LPPGLLANFTLLR (13aa)
-
- Hex:7 HexNAc:6 NeuAc:3 / N-Linked (avg mass : 3245.9558)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- LPPGLLANFTLLR (13aa)
-
- Hex:6 HexNAc:5 dHex:3 NeuAc:3 / N-Linked (avg mass : 3319.0474)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- MFSQNDTR (8aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
